Psychiatry
Resource Center
Featured
09/30/2024
Miranda Manier, BA
Two randomized, double-blind studies demonstrated that a new antipsychotic treatment for adult patients with schizophrenia may lead to a meaningful reduction in symptoms.
09/30/2024
09/19/2024
Josh Hamilton, DNP, APRN, BC, CNE, FAANP
Josh Hamilton, DNP, APRN, BC, CNE, FA...
In this video, Josh Hamilton, DNP, APRN, BC, CNE, FAANP, details his session “Precision Medicine: Biomarkers & The Treatment of Depression” at PUPC 2024. In his session, Dr Hamilton described how clinicians...
09/19/2024
09/03/2024
In this episode, W. Clay Jackson, MD, DipTH, speaks about the differences between schizophrenia and dissociative identity disorder, how patients with schizophrenia should be managed, and the gaps in the...
09/03/2024
Interactive Features
04/23/2024
Early onset of mental disorders may result in a lifetime burden on patients. Are you familiar with how prevalent mental disorders are among youth?
04/23/2024
04/12/2024
Augmentation strategies are typically implemented when remission of major depressive disorder is not achieved. Which agents are effective augmentation therapies? Test your knowledge with our quiz!
04/12/2024
04/08/2024
Male patients with schizophrenia tend to show symptoms earlier than female patients. Do you know the common age of onset of schizophrenia? Take the pop quiz and find out!
04/08/2024
03/11/2024
The symptoms of schizophrenia include negative and positive symptoms. The negative symptoms of schizophrenia include an absence of facial expressions, emotional response, and interest in the world. Do you...
03/11/2024
02/24/2024
A collaborative care system has been shown to improve diagnosis and treatment of psychiatric disorders in primary care. When treating patients with psychological disorders, do you employ a collaborative...
02/24/2024
Clinical Insights
09/19/2024
Josh Hamilton, DNP, APRN, BC, CNE, FAANP
Josh Hamilton, DNP, APRN, BC, CNE, FA...
In this video, Josh Hamilton, DNP, APRN, BC, CNE, FAANP, details his session “Precision Medicine: Biomarkers & The Treatment of Depression” at PUPC 2024. In his session, Dr Hamilton described how clinicians...
09/19/2024
09/03/2024
In this episode, W. Clay Jackson, MD, DipTH, speaks about the differences between schizophrenia and dissociative identity disorder, how patients with schizophrenia should be managed, and the gaps in the...
09/03/2024
04/13/2024
James W. Antoon, MD, PhD, MPH
James W. Antoon, MD, PhD, MPH
In this expert Q and A, James W. Antoon, MD, PhD, MPH, discusses the results of his team's recent study examining the rate of neuropsychiatric events associated with influenza infection and treatment in...
04/13/2024
02/05/2024
In this Q&A, W. Clay Jackson, MD, DipTH, speaks about various aspects of schizophrenia, including the symptoms, risk factors, and associated controversies surrounding these risk factors.
02/05/2024
01/10/2024
Andrew F. Leuchter, MD
In this video, Andrew F. Leuchter, MD, discusses his team’s study that examined pupillary light reflex (PLR) as a pre-treatment biomarker for repetitive Transcranial Magnetic Stimulation (rTMS) in patients...
01/10/2024
